Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|November 9, 2024
Bendamustine-rituximab elicits dual tumoricidal and immunomodulatory responses via cGAS-STING activation in diffuse large B-cell lymphomaRuipei Xiao, Wenli Zhao, Wei Lin, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Novel function of IFN-gamma: negative regulation of dendritic cell migration and T cell primingXiaodong Wu, Wanqiu Hou, Shuhui Sun, et al.Cancer Cell|June 13, 2018
Th9 Cells Represent a Unique Subset of CD4<sup>+</sup> T Cells Endowed with the Ability to Eradicate Advanced TumorsYong Lu, Qiang Wang, Gang Xue, et al.Science Signaling|October 12, 2017
Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T<sub>H</sub>9 cells programmed by IL-7Enguang Bi, Xingzhe Ma, Yong Lu, et al.Haematologica|February 22, 2020
Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myelomaRong Li, Chengyun Zheng, Qiang Wang, et al.Journal for Immunotherapy of Cancer|February 6, 2019
TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathwaysYuxue Jiang, Jintong Chen, Enguang Bi, et al.Journal of Hematology & Oncology|April 18, 2014
The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expressionXiaolei Wei, Meng Xu, Yongqiang Wei, et al.Cell Metabolism|March 10, 2021
CD36-mediated ferroptosis dampens intratumoral CD8<sup>+</sup> T cell effector function and impairs their antitumor abilityXingzhe Ma, Liuling Xiao, Lintao Liu, et al.Journal of Cell Science|April 30, 2005
BCL6 suppresses RhoA activity to alter macrophage morphology and motilityFiona J Pixley, Ying Xiong, Raymond Yick-Loi Yu, et al.Nature Genetics|June 21, 2016
Functional characterization of somatic mutations in cancer using network-based inference of protein activityMariano J Alvarez, Yao Shen, Federico M Giorgi, et al.Pageof 8